Plasma fatty acid metabolic profile coupled with uncorrelated linear discriminant analysis to diagnose and biomarker screening of type 2 diabetes and type 2 diabetic coronary heart diseases

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Metabolomics

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11306-007-0098-7
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of diabetes mellitus

  2008cited by this paper
• A medical bioinformatics approach for metabolic disorders: Biomedical data prediction, modeling, and systematic analysis

  2006cited by this paper
• Feature Reduction via Generalized Uncorrelated Linear Discriminant Analysis

  2006influential reference
• Plasma fatty acid metabolic profiling and biomarkers of type 2 diabetes mellitus based on GC/MS and PLS‐LDA

  2006cited by this paper
• Lipidome and disease

  2006cited by this paper
• Discovery and development of biomarkers of neurological disease.

  2005cited by this paper
• Metabolomic approaches to mitochondrial disease: correlation of urine organic acids.

  2004cited by this paper
• Metabolomics – the link between genotypes and phenotypes

  2004influential reference
• Free fatty acids and type 2 diabetes mellitus.

  2003cited by this paper
• Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis.

  2003influential reference
• Metabonomics: a platform for studying drug toxicity and gene function

  2002cited by this paper
• Diabetes mellitus and cardiovascular disease.

  2002cited by this paper
• Chemometric contributions to the evolution of metabonomics: mathematical solutions to characterising and interpreting complex biological NMR spectra.

  2002cited by this paper
• Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics

  2002cited by this paper
• Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS‐DA

  2002influential reference
• Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution 1H NMR spectra of biofluids.

  2002cited by this paper
• Application of metabolomics to plant genotype discrimination using statistics and machine learning

  2002cited by this paper
• Diabetes Mellitus and Cardiovascular Disease

  2001cited by this paper
• NMR of biofluids and pattern recognition: assessing the impact of NMR parameters on the principal component analysis of urine from rat and mouse.

  2001cited by this paper
• On the optimization of classes for the assignment of unidentified reading frames in functional genomics programmes: the need for machine learning.

  2000cited by this paper
• Free fatty acids and pathogenesis of type 2 diabetes mellitus.

  2000cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Free fatty acids, insulin resistance, and type 2 diabetes mellitus.

  1999cited by this paper
• Impact of Diabetes on Mortality After the First Myocardial Infarction

  1998cited by this paper
• Systematic functional analysis of the yeast genome.

  1998cited by this paper
• Prevalence of Cardiovascular and Renal Complications in Older Adults With Normal or Impaired Glucose Tolerance or NIDDM: A population-based study

  1993cited by this paper
• Metabolic profiling of plants: a new diagnostic technique

  1991cited by this paper
• WHO MONICA Project: assessing CHD mortality and morbidity.

  1989cited by this paper
• The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group.

  1989cited by this paper
• Trends and determinants of ischaemic heart disease mortality in Finland: with special reference to a possible levelling off in the early 1980s.

  1989cited by this paper
• Diabetic Myocardial Infarction: Interaction of Diabetes With Other Preinfarction Risk Factors

  1989cited by this paper
• Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus.

  1988cited by this paper

• A variable selection method based on multicollinearity reduction for food origin traceability identification

  2025cites this paper
• Predicting 1-year mortality of patients with diabetes mellitus in Kazakhstan based on administrative health data using machine learning

  2023cites this paper
• Fisher’s Linear Discriminant Function Analysis and its Potential Utility as a Tool for the Assessment of Health-and-Wellness Programs in Indigenous Communities

  2020cites this paper
• Chemometrics in instrumental analysis of complex systems—in honor and memory of Yi‐Zeng Liang

  2018cites this paper
• Metabolite and hormone rhythms : the effect of obesity type two diabetes and meal timing.

  2017cites this paper
• Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.

  2017cites this paper
• Metabolomics for the masses: The future of metabolomics in a personalized world

  2017cites this paper
• Stable biomarker screening and classification by subsampling-based sparse regularization coupled with support vector machines in metabolomics

  2017cites this paper
• A Lipidomic Approach Reveals Colostrum and Milk Biomarkers Predictive of Production-Related Metabolic Disease in Dairy Cows

  2017cites this paper
• A Predictive Metabolic Signature for the Transition From Gestational Diabetes Mellitus to Type 2 Diabetes

  2016cites this paper
• Mechanism by which Metformin Influence Metabolic Changes in Human:A Systematic-Review

  2016cites this paper
• Is uncorrelated linear discriminant analysis really a new method

  2015cites this paper
• Delineating a Metabolomic Signature for the Transition from Gestational Diabetes to Type 2 Diabetes

  2015influential citation
• Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.

  2015cites this paper
• Untargeted fatty acid profiles based on the selected ion monitoring mode.

  2014cites this paper
• Application of random forests to select premium quality vegetable oils by their fatty acid composition.

  2014cites this paper
• Detection and identification of extra virgin olive oil adulteration by GC-MS combined with chemometrics.

  2013cites this paper
• [Plasma fatty acid metabolic profiles for traditional Chinese medicine syndrome differentiation in diabetic patients using uncorrelated linear discriminant analysis].

  2013cites this paper
• Metabolomics in rheumatic diseases: the potential of an emerging methodology for improved patient diagnosis, prognosis, and treatment efficacy.

  2013cites this paper
• Discrimination of type 2 diabetes mellitus corresponding to different traditional Chinese medicine syndromes based on plasma fatty acid profiles and chemometric methods.

  2012cites this paper
• Applications of mass spectrometry to metabolomics and metabonomics: detection of biomarkers of aging and of age-related diseases.

  2012cites this paper
• THEMATIC REVIEW Metabolomics in diabetes research

  2012cites this paper
• Metabolomics in diabetes research.

  2012cites this paper
• Establishment of reliable mass spectra and retention indices library: identification of fatty acids in human plasma without authentic standards.

  2012cites this paper
• Metabolomics data and the biomarker qualification process

  2012cites this paper
• Targeted and non-targeted metabolic time trajectory in plasma of patients after acute coronary syndrome.

  2011cites this paper
• Profiling of non-esterified fatty acids in human plasma using liquid chromatography-electron ionization mass spectrometry

  2011cites this paper
• Serum Metabolic Fingerprinting to Detect Human Nasopharyngeal Carcinoma Based on Gas Chromatography-Mass Spectrometry and Partial Least Squares-Linear Discriminant Analysis

  2011cites this paper
• Plasma metabolic fingerprinting of childhood obesity by GC/MS in conjunction with multivariate statistical analysis.

  2010cites this paper
• Quantitative LC-ESI-MS/MS metabolic profiling method for fatty acids and lipophilic metabolites in fermentation broths from β-lactam antibiotics production

  2010cites this paper
• [Classification of diabetes deficiency syndromes based on plasma fatty acid metabolic profilings using precolumn derivatization quantitative method].

  2010cites this paper
• Metabolomic analysis of human vitreous humor differentiates ocular inflammatory disease

  2009cites this paper
• Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC-oaTOF-MS system.

  2009cites this paper
• Metabonomic characterization of early atherosclerosis in hamsters with induced cholesterol

  2009cites this paper
• Metabolomics in evaluation of glucose disorders

  2009cites this paper
• Automics: an integrated platform for NMR-based metabonomics spectral processing and data analysis

  2009cites this paper
• From differentiating metabolites to biomarkers

  2009cites this paper
• Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: Biomarker discovery for diabetes mellitus.

  2009cites this paper
• GC–MS Based Plasma Metabolic Profiling of Type 2 Diabetes Mellitus

  2009cites this paper
• Metabolomic analysis of human disease and its application to the eye

  2009cites this paper
• of Birmingham Metabolomic analysis of human disease and its application to the eye

  year unknowncites this paper
• Metabolomic Analysis of Human Vitreous Humor Differentiates Ocular Inflammatory Disease

  year unknowncites this paper